Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP-EF: Oxygen in HeFPEF
NCT02949531Phase 2Completed
- Sponsor
- Hull University Teaching Hospitals
- Start
- Nov 2016
- Primary completion
- Feb 2017
- Modality
- Inhalation Devices
01
Overview
Phase 2, randomised, single-blind trial of oxygen in heart failure with preserved ejection fraction (HFpEF) (3 arms), sponsored by Hull University Teaching Hospitals. Primary endpoint: Change in exercise time at 3 weeks. Started Nov 2016; status: completed.
02
Drugs
oxygen
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT02949531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02949531.